Cite
Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients.
MLA
Attolico, Immacolata, et al. “Serological Response Following BNT162b2 Anti‐SARS‐CoV‐2 MRNA Vaccination in Haematopoietic Stem Cell Transplantation Patients.” British Journal of Haematology, vol. 196, no. 4, Feb. 2022, pp. 928–31. EBSCOhost, https://doi.org/10.1111/bjh.17873.
APA
Attolico, I., Tarantini, F., Carluccio, P., Schifone, C. P., Delia, M., Gagliardi, V. P., Perrone, T., Gaudio, F., Longo, C., Giordano, A., Sgherza, N., Curci, P., Rizzi, R., Ricco, A., Russo Rossi, A., Albano, F., Larocca, A. M. V., Vimercati, L., Tafuri, S., & Musto, P. (2022). Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients. British Journal of Haematology, 196(4), 928–931. https://doi.org/10.1111/bjh.17873
Chicago
Attolico, Immacolata, Francesco Tarantini, Paola Carluccio, Claudia Pia Schifone, Mario Delia, Vito Pier Gagliardi, Tommasina Perrone, et al. 2022. “Serological Response Following BNT162b2 Anti‐SARS‐CoV‐2 MRNA Vaccination in Haematopoietic Stem Cell Transplantation Patients.” British Journal of Haematology 196 (4): 928–31. doi:10.1111/bjh.17873.